|
|
 |
|
Viewing report
|
|
|
|
Generics in the Netherlands
MarketLine, Sep 2011, Pages: 43
Introduction
Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
-For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume. All currency conversions were calculated at constant average annual 2010 exchange rates.
-The Dutch generics market had total revenue of $1.1 billion in 2010, representing a compound annual growth rate (CAGR) of 6.3% between 2006 and 2010.
-Percentage of generics share in total pharma market increased with a CAGR of 3.6% between 2006-2010, to reach 59.7% of total pharma market in 2010.
-The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.6% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $1.4 billion by the end of 2015.
Features
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in the Netherlands
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in the Netherlands
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands generics market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the Netherlands economy
Key Questions Answered
What was the size of the Netherlands generics market by value in 2010?
What will be the size of the Netherlands generics market in 2015?
What factors are affecting the strength of competition in the Netherlands generics market?
How has the market performed over the last five years?
How large is the Netherlands’s generics market in relation to its regional counterparts?
|
|
|
|
